The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Cutting Edge: Inflammatory Responses Can Be Triggered by TREM-1, a Novel Receptor Expressed on Neutrophils and Monocytes
Abstract
We have identified new activating receptors of the Ig superfamily expressed on human myeloid cells, called TREM (triggering receptor expressed on myeloid cells). TREM-1 is selectively expressed on blood neutrophils and a subset of monocytes and is up-regulated by bacterial LPS. Engagement of TREM-1 triggers secretion of IL-8, monocyte chemotactic protein-1, and TNF-alpha and induces neutrophil degranulation. Intracellularly, TREM-1 induces Ca2+ mobilization and tyrosine phosphorylation of extracellular signal-related kinase 1 (ERK1), ERK2 and phospholipase C-gamma. To mediate activation, TREM-1 associates with the transmembrane adapter molecule DAP12. Thus, TREM-1 mediates activation of neutrophil and monocytes, and may have a predominant role in inflammatory responses.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“TREM2 expression was first observed in macrophages and dendritic cells, but not granulocytes or monocytes (9–11).”
From Trem2 promotes anti-inflammatory responses in microglia and is suppressed under pro-inflammatory conditions (2020) · cites this paper as [9]
Citations
Cites
Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm
Springer, T. A. (1994) · Cell · doi:10.1016/0092-8674(94)90337-9 · Cited by 7,009
Lanier, L. L. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.359 · Cited by 1,641
Recognition of Gram-negative bacteria and endotoxin by the innate immune system
Ulevitch, R. J., & Tobias, P. S. (1999) · Current Opinion in Immunology · doi:10.1016/s0952-7915(99)80004-1 · Cited by 567
Cantoni, C., Bottino, C., Vitale, M., Pessino, A. M., Augugliaro, R., Malaspina, A., Parolini, S., Moretta, L., Moretta, A., & Biassoni, R. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.5.787 · Cited by 450
Cella, M., Döhring, C., Samaridis, J., Dessing, M., Brockhaus, M., Lanzavecchia, A., & Colonna, M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.10.1743 · Cited by 430
Bakker, A. B. H., Baker, E. G., Sutherland, G. R., Phillips, J. H., & Lanier, L. L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.17.9792 · Cited by 210
Nakajima, H., Samaridis, J., Ångman, L., & Colonna, M. (1999) · PubMed · Cited by 173
Dietrich, J., Cella, M., Seiffert, M., Bühring, H., & Colonna, M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.1.9 · Cited by 172
Nakajima, H., Samaridis, J., Ångman, L., & Colonna, M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.1.5 · Cited by 152
Kubagawa, H., Chen, C., Ho, L. H., Shimada, T., Gartland, L., Mashburn, C. B., Uehara, T., Ravetch, J. V., & Cooper, M. D. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.2.309 · Cited by 148
Research works printed but not linked: 13
- 1999, Curr. Opin. Immunol., 19
- 1995, Semin. Cell Biol., 345
- 1999, J. Immunol., 5
- 1998, J. Immunol., 4042
- 1999, J. Exp. Med., 309
- 2000, J. Immunol., 9
- 1999, Proc. Natl. Acad. Sci. USA, 9792
- 1998, Annu. Rev. Immunol., 359
- 1999, J. Exp. Med., 787
- 1991, Trends Biotechnol., 109
- 1997, J. Exp. Med., 1743
- 1997, The Leukocyte Antigen Facts Book
- 1994, Cell, 301
Cited by
Sorted by citations
Kalil, A. C., Metersky, M. L., Klompas, M., Muscedere, J., Sweeney, D. A., Palmer, L. B., Napolitano, L. M., O'Grady, N. P., Bartlett, J. G., Carratalà, J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw353 · Cited by 3,892
“TREM-1 is a member of the immunoglobulin superfamily that has been shown to be strongly expressed on the neutrophils and monocytes infiltrating tissues invaded by bacteria or fungi [107].”
The immunopathogenesis of sepsis
Cohen, J. (2002) · Nature · doi:10.1038/nature01326 · Cited by 2,742
Variant of TREM2 Associated with the Risk of Alzheimer's Disease
Jonsson, T., Stefansson, H., Steinberg, S., Jonsdottir, I., Jonsson, P. V., Snaedal, J., Bjornsson, S., Huttenlocher, J., Levey, A. I., Lah, J. J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211103 · Cited by 2,558
DAMP-sensing receptors in sterile inflammation and inflammatory diseases
Gong, T., Liu, L., Jiang, W., & Zhou, R. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-019-0215-7 · Cited by 1,672
Neutrophils, from Marrow to Microbes
Borregaard, N. (2010) · Immunity · doi:10.1016/j.immuni.2010.11.011 · Cited by 1,679
“…cells (TREM-1) (by ligands not yet identified; Ford and McVicar, 2009), which is upregulated (Bouchon et al., 2000, 2001) and signals through DAP12 (presented earlier) (Bouchon et al., 2000; Tessarz and Cerwenka, 2008), may lead to degranulation and transcriptional activity (Bouchon et al., 2000).”
BackgroundTREM-1 amplifies inflammation and is a crucial mediator of septic shock
Bouchon, A., Facchetti, F., Weigand, M. A., & Colonna, M. (2001) · Nature · doi:10.1038/35074114 · Cited by 1,092
TREM2 — a key player in microglial biology and Alzheimer disease
Ulland, T. K., & Colonna, M. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0072-1 · Cited by 735
Self-citationComparison of gene expression profiles between human and mouse monocyte subsets
Ingersoll, M. A., Spanbroek, R., Lottaz, C., Gautier, E. L., Frankenberger, M., Hoffmann, R. F. G., Lang, R., Haniffa, M. A., Collin, M. P., Tacke, F., et al. (2009) · Blood · doi:10.1182/blood-2009-07-235028 · Cited by 779
TREMs in the immune system and beyond
Colonna, M. (2003) · Nature Reviews Immunology · doi:10.1038/nri1106 · Cited by 701
Self-citationPaloneva, J., Manninen, T., Christman, G., Hovanes, K., Mandelin, J., Adolfsson, R., Bianchin, M., Bird, T., Miranda, R., Salmaggi, A., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/342259 · Cited by 683
“2001a), whereas TREM2 is expressed on macrophages and monocyte-derived dendritic cells, suggesting that TREM2 plays a role in chronic, rather than in acute, inflammation (Bouchon et al. 2000).”
BackgroundInfluentialNeutrophils in development of multiple organ failure in sepsis
Brown, K., Brain, S. D., Pearson, J. D., Edgeworth, J. D., Sm, L., & Treacher, D. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69005-3 · Cited by 652
Soluble Triggering Receptor Expressed on Myeloid Cells and the Diagnosis of Pneumonia
Gibot, S., Cravoisy, A., Lévy, B., Béné, M. C., Faure, G. C., & Bollaert, P. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031544 · Cited by 640
Neutrophil cell surface receptors and their intracellular signal transduction pathways
Futosi, K., Fodor, S., & Mócsai, A. (2013) · International Immunopharmacology · doi:10.1016/j.intimp.2013.06.034 · Cited by 642
“Those include DAP12and FcRγ-associated receptors such as TREM-1 [226,227] and OSCAR [228]; the Neisseria recognition receptor CEACAM3 [229,230]; as well as scavenger receptors, complement receptors and various intracellular lipid-sensing receptors.”
BackgroundThe role of platelets in inflammation
Storey, R. F., & Thomas, M. (2015) · Thrombosis and Haemostasis · doi:10.1160/th14-12-1067 · Cited by 619
“Mediates leukocyte activation and engagement of leukocyte TREM1 induces secretion of IL-8, TNFα and CCL2 (125) Presents IL-1β (126), RANTES (26) to the endothelium.”
BackgroundInfluentialThe TREM receptor family and signal integration
Klesney‐Tait, J., Turnbull, I. R., & Colonna, M. (2006) · Nature Immunology · doi:10.1038/ni1411 · Cited by 602
New insights into the role of TREM2 in Alzheimer’s disease
Gratuze, M., Leyns, C. E. G., & Holtzman, D. M. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0298-9 · Cited by 489
New Approaches to Sepsis: Molecular Diagnostics and Biomarkers
Reinhart, K., Bauer, M. W., Riedemann, N. C., & Hartog, C. S. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.00016-12 · Cited by 546
“Studies have shown that the expression of TREM-1 is greatly upregulated in the presence of bacteria or fungi in cell culture, peritoneal lavage fluid, and tissue samples from patients infected with these microorganisms (36, 63).”
BackgroundOxidative stress and gene expression in sepsis
Macdonald, J., Galley, H. F., & Webster, N. R. (2003) · British Journal of Anaesthesia · doi:10.1093/bja/aeg034 · Cited by 497
Activation of microglia and astrocytes: a roadway to neuroinflammation and Alzheimer’s disease
Kaur, D., Sharma, V., & Deshmukh, R. R. (2019) · Inflammopharmacology · doi:10.1007/s10787-019-00580-x · Cited by 503
Bouchon, A., Hernández-Munain, C., Cella, M., & Colonna, M. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.8.1111 · Cited by 460
“TREM-1 is preferentially expressed on neutrophils and a subset of blood monocytes (53).”
BackgroundResultInfluentialGibot, S., Kolopp‐Sarda, M., Béné, M. C., Cravoisy, A., Lévy, B., Faure, G. C., & Bollaert, P. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-1-200407060-00009 · Cited by 403
“The triggering receptor expressed on myeloid cells-1 (TREM-1) is a member of the immunoglobulin superfamily, and its expression is upregulated on phagocytic cells in the presence of bacteria or fungi (12).”
Impact of vitamin D on immune function: lessons learned from genome-wide analysis
Chun, R. F., Liu, P. T., Modlin, R. L., Adams, J. S., & Hewison, M. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00151 · Cited by 414
“The increasing availability of gene/protein expression databases for different cell types means that this type of strategy is likely to become a more prominent feature of genome-wide expression analyses in the future.”
BackgroundColonna, M. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-023-00837-1 · Cited by 394
Self-citationGuerreiro, R. J., Lohmann, E., Brás, J. M., Gibbs, J. R., Rohrer, J. D., Gurunlian, N., Dursun, B., Bilgic, B., Hanagasi, H., Gurvit, H., et al. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.579 · Cited by 374
“It may be involved in chronic inflammation by triggering the production of constitutive rather than inflammatory chemokines and cytokines.(22) Interestingly, mutations in both these genes have been associated with PLOSL or Nasu-Hakola disease.”
Chen, S., Peng, J., Sherchan, P., Ma, Y., Xiang, S., Yan, F., Zhao, H., Jiang, Y. Q., Wang, N., Zhang, J. H., et al. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01853-x · Cited by 392
“It contains an ectodomain, a transmembrane domain, and a short cytoplasmic tail [13].”
Schenk, M., Bouchon, A., Seibold, F., & Mueller, C. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30602 · Cited by 365
Soluble TREM2 induces inflammatory responses and enhances microglial survival
Zhong, L., Chen, X., Wang, T., Wang, Z., Liao, C., Wang, Z., Huang, R., Wang, D., Li, X., Wu, L., et al. (2017) · The Journal of Experimental Medicine · doi:10.1084/jem.20160844 · Cited by 372
“20160844 597 IntroductIon TREM2 is a member of the Ig superfamily that contains an ectodomain, a transmembrane domain, and a short cytoplasmic tail (Bouchon et al., 2000).”
Gibot, S., Kolopp‐Sarda, M., Béné, M.-C., Bollaert, P., Lozniewski, A., Mory, F., Lévy, B., & Faure, G. C. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040708 · Cited by 361
Schmid, C. D., Sautkulis, L. N., Danielson, P. E., Cooper, J., Hasel, K. W., Hilbush, B. S., Sutcliffe, J. G., & Carson, M. J. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01243.x · Cited by 351
“killer cells, T cells or granulocytes (Bouchon et al. 2000; Bouchon et al. 2001; Daws et al. 2001).”
BackgroundInfluentialOn guard—activating NK cell receptors
Lanier, L. L. (2001) · Nature Immunology · doi:10.1038/83130 · Cited by 343
Bleharski, J. R., Kiessler, V., Buonsanti, C., Sieling, P. A., Stenger, S., Colonna, M., & Modlin, R. L. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.7.3812 · Cited by 352
“To activate monocytes through TREM-1, an agonist anti-TREM-1 mAb (clone 9E2, mouse IgG1) was generated and purified as described elsewhere (10, 15).”
BackgroundMethodInfluentialElucidating the Role of TREM2 in Alzheimer’s Disease
Ulrich, J. D., Ulland, T. K., Colonna, M., & Holtzman, D. M. (2017) · Neuron · doi:10.1016/j.neuron.2017.02.042 · Cited by 325
“TREM2 associates with the signaling adaptor protein DAP12 through an electrostatic interaction between a conserved lysine in TREM2 and aspartic acid in DAP12 within the transmembrane region (Figure 1) (Bouchon et al., 2000).”
BackgroundImmune Signaling in Neurodegeneration
Hammond, T. R., Marsh, S. E., & Stevens, B. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.016 · Cited by 336
“It was first cloned in 2000 by Marco Colonna and colleagues (Bouchon et al., 2000) and is part of a series of Trem and Trem-like genes on human chromosome 6 (mouse chr.”
BackgroundNeutrophil dysregulation during sepsis: an overview and update
Shen, X., Cao, K., Jiang, J., Guan, W., & Du, J. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13112 · Cited by 346
Coding variants in TREM2 increase risk for Alzheimer's disease
Jin, S. C., Benitez, B. A., Karch, C. M., Cooper, B., Skorupa, T., Carrell, D., Norton, J. B., Hsu, S., Harari, O., Cai, Y., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu277 · Cited by 314
“TREM2 is a Type I transmembrane receptor protein expressed on myeloid cells including microglia, monocyte-derived dendritic cells, osteoclasts and bone-marrow derived macrophages (31,32).”
BackgroundDAP10‐ and DAP12‐associated receptors in innate immunity
Lanier, L. L. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00720.x · Cited by 332
DAP12/TREM2 deficiency results in impaired osteoclast differentiation and osteoporotic features
Paloneva, J., Mandelin, J., Kiialainen, A., Böhling, T., Prudlo, J., Hakola, P., Haltia, M., Konttinen, Y. T., & Peltonen, L. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030027 · Cited by 318
“On the cell membrane of monocyte-derived dendritic cells, DAP12 is expressed as a complex with TREM2 (8, 9).”
BackgroundEnhanced Toll-like receptor responses in the absence of signaling adaptor DAP12
Hamerman, J. A., Tchao, N. K., Lowell, C. A., & Lanier, L. L. (2005) · Nature Immunology · doi:10.1038/ni1204 · Cited by 325
Immune cells: free radicals and antioxidants in sepsis
Víctor, V. M., Rocha, M., & la Fuente, M. D. (2004) · International Immunopharmacology · doi:10.1016/j.intimp.2004.01.020 · Cited by 319
Wunderlich, P., Glebov, K., Kemmerling, N., Tien, N. T., Neumann, H., & Walter, J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.517540 · Cited by 296
Semple, J. W., & Freedman, J. J. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0205-1 · Cited by 319
“TREM-1 is a member of the v-type immunoglobulin super family and is expressed on neutrophils and monocytes [116].”
BackgroundThe Triggering Receptor Expressed on Myeloid Cells 2 Binds Apolipoprotein E
Bailey, C. C., DeVaux, L. B., & Farzan, M. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.677286 · Cited by 303
“Triggering receptor expressed on myeloid cells 2 (TREM2)(2) is a type I transmembrane protein with a single, extracellular, Ig-like V-type domain (1, 2).”
BackgroundPattern Recognition by TREM-2: Binding of Anionic Ligands
Daws, M. R., Sullam, P. M., Niemi, E. C., Chen, T. T., Tchao, N. K., & Seaman, W. E. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.2.594 · Cited by 291
“Three members of the mouse TREM family have been studied: TREM-1 (1, 4), TREM-2 (3, 5), and TREM-3 (2).”
BackgroundMethodInfluentialvan Gils, J. M., Zwaginga, J. J., & Hordijk, P. L. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0708400 · Cited by 303
“Similarly, engagement of CD40 with CD40L, but also TREM-1 ligation, results in an increase in monocyte adhesive capacity by up-regulation of 1- and 2-integrins [54, 77].”
BackgroundInfluentialMicroglial TREM2/DAP12 signaling: a double-edged sword in neural diseases
Konishi, H., & Kiyama, H. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00206 · Cited by 300
Blockade of TREM‐2 exacerbates experimental autoimmune encephalomyelitis
Piccio, L., Buonsanti, C., Mariani, M., Cella, M., Gilfillan, S., Cross, A. H., Colonna, M., & Panina‐Bordignon, P. (2007) · European Journal of Immunology · doi:10.1002/eji.200636837 · Cited by 284
Self-citationGlial activation and inflammation along the Alzheimer’s disease continuum
Nordengen, K., Kirsebom, B.-E., Henjum, K., Selnes, P., Gísladóttir, B., Wettergreen, M., Torsetnes, S. B., Grøntvedt, G. R., Waterloo, K. K., Aarsland, D., et al. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1399-2 · Cited by 274
Colonna, M., & Facchetti, F. (2003) · The Journal of Infectious Diseases · doi:10.1086/374754 · Cited by 281
“TREM-1 is expressed at late stages of myeloid cell differentiation [25] and associates with DAP12 for signaling and function [21].”
BackgroundMethodInfluentialRaggi, F., Pelassa, S., Pierobon, D., Penco, F., Gattorno, M., Novelli, F., Eva, A., Varesio, L., Giovarelli, M., & Bosco, M. C. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01097 · Cited by 294
Xu, P., Zhang, X., Liu, Q., Xie, Y., Shi, X., Chen, J., Li, Y., Guo, H., Sun, R., Hong, Y., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1777-9 · Cited by 273
Wang, X., He, Q., Zhou, C., Xu, Y., Liu, D., Fujiwara, N., Kubota, N., Click, A., Henderson, P., Vancil, J., et al. (2023) · Immunity · doi:10.1016/j.immuni.2022.11.013 · Cited by 262
Mutual activation of natural killer cells and monocytes mediated by NKp80-AICL interaction
Welte, S., Kuttruff, S., Waldhauer, I., & Steinle, A. (2006) · Nature Immunology · doi:10.1038/ni1402 · Cited by 277
Microglia and aging: the role of the TREM2-DAP12 and CX3CL1-CX3CR1 axes
Mecca, C., Giambanco, I., Donato, R., & Arcuri, C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010318 · Cited by 258
“TREM2 is a member of the Triggering Receptor Expressed on Myeloid Cells transmembrane glycoproteins, which belongs to the single immunoglobulin variable (IgV) domain receptor family [46].”
BackgroundThe genetic causes of basal ganglia calcification, dementia, and bone cysts: DAP12 and TREM2
Klünemann, H. H., Ridha, B. H., Magy, L., Wherrett, J. R., Hemelsoet, D. M., Keen, R. W., De Bleecker, J. L., Rossor, M. N., Marienhagen, J., Klein, H. E., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000160304.00003.ca · Cited by 254
Beyond Hemostasis: Platelet Innate Immune Interactions and Thromboinflammation
Mandel, J., Casari, M., Stepanyan, M. G., Martyanov, A. A., & Deppermann, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073868 · Cited by 288
“Platelets and monocytes also come in contact through CD40L–CD40 [182] interactions and monocytetriggering receptors expressed on myeloid cell 1 (TREM-1) to TLT-1 on platelets [183,184].”
BackgroundTREM-1 and its potential ligands in non-infectious diseases: from biology to clinical perspectives
Tammaro, A., Derive, M., Gibot, S., Leemans, J. C., Florquin, S., & Dessing, M. C. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.02.043 · Cited by 253
The Role of Macrophages and Dendritic Cells in the Initiation of Inflammation in IBD
Steinbach, E. C., & Plevy, S. E. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e3182a69dca · Cited by 269
“Conversely, triggering receptor expressed on myeloid cells-1 (TREM-1) amplifies TLR-induced inflammatory responses in macrophages, and blocking its activity attenuates murine colitis.(100,101) Indeed, resident LP macrophages do not express TREM-1, but abundant TREM-1–expressing LP macrophages can be found in patients…”
BackgroundInnate and adaptive immunity: specificities and signaling hierarchies revisited
Vivier, É., & MALISSEN, B. (2004) · Nature Immunology · doi:10.1038/ni1153 · Cited by 246
Activating and inhibitory functions of DAP12
Turnbull, I. R., & Colonna, M. (2007) · Nature Reviews Immunology · doi:10.1038/nri2014 · Cited by 273
Role of ITAM‐containing adapter proteins and their receptors in the immune system and bone
Humphrey, M. B., Lanier, L. L., & Nakamura, M. C. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00325.x · Cited by 244
“DAP12-deficient mice were more susceptible to endotoxic shock in a galactosamine sensitized LPS model and demonstrated enhanced resistance to infection by Listeria monocytogenes (71).”
BackgroundInfluentialGibot, S., Cravoisy, A., Kolopp‐Sarda, M., Béné, M. C., Faure, G. C., Bollaert, P., & Lévy, B. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000159089.16462.4a · Cited by 230
TREM-1: intracellular signaling pathways and interaction with pattern recognition receptors
Arts, R. J. W., Joosten, L. A. B., van der Meer, J. W. M., & Netea, M. G. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0312145 · Cited by 242
“First, NTAL represses the TREM-1-induced phosphorylation of ERK and the production of TNF- and IL-8, by binding Grb2 and Sos1, which results in less activity of the RAS pathway [1, 39, 42].”
BackgroundDAP12-deficient mice fail to develop autoimmunity due to impaired antigen priming.
Bakker, A. B., Hoek, R., Cerwenka, A., Blom, B., Lucian, L., McNeil, T., Murray, R., Phillips, L., Sedgwick, J., & Lanier, L. (2000) · Immunity · doi:10.1016/s1074-7613(00)00034-0 · Cited by 269
Impaired Synaptic Function in the Microglial KARAP/DAP12-Deficient Mouse
Roumier, A., Béchade, C., Poncer, J. C., Smalla, K., Tomasello, E., Vivier, É., Gundelfinger, E. D., Triller, A., & Bessis, A. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.2251-04.2004 · Cited by 248
“KARAP/DAP12 is expressed in multiple cell types derived from the myeloid lineage (Bouchon et al., 2000), but its presence in microglia was only mentioned as unpublished results (Bakker et al.”
BackgroundResultXu, P., Hong, Y., Xie, Y., et al. (2020) · Translational Stroke Research · doi:10.1007/s12975-020-00840-x · Cited by 224
Pattern recognition receptor function in neutrophils
Thomas, C. J., & Schroder, K. (2013) · Trends in Immunology · doi:10.1016/j.it.2013.02.008 · Cited by 220
Securing the immune tightrope: mononuclear phagocytes in the intestinal lamina propria
Varol, C., Zigmond, E., & Jung, S. (2010) · Nature reviews. Immunology · doi:10.1038/nri2778 · Cited by 222
Liu, W., Taso, O., Wang, R., Bayram, S., Graham, A. C., Garcia-Reitboeck, P., Mallach, A., Andrews, W. D., Piers, T. M., Botia, J. A., et al. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa209 · Cited by 214
“TREM2 expression was first observed in macrophages and dendritic cells, but not granulocytes or monocytes (Bouchon et al. 2000; Bouchon et al. 2001; Daws et al. 2001).”
BackgroundTREM2, microglia, and Alzheimer’s disease.
Qin, Q., Teng, Z., Liu, C., Li, Q., Yin, Y., & Tang, Y. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111438 · Cited by 219
TREM-1 ligand expression on platelets enhances neutrophil activation
Haselmayer, P., Große‐Hovest, L., von Landenberg, P., Schild, H., & Radsak, M. P. (2007) · Blood · doi:10.1182/blood-2007-01-069195 · Cited by 211
TREM-2 promotes macrophage survival and lung disease after respiratory viral infection
Wu, K., Byers, D. E., Jin, X., Agapov, E., Alexander-Brett, J., Patel, A. C., Cella, M., Gilfilan, S., Colonna, M., Kober, D. L., et al. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20141732 · Cited by 207
“2, C and D), consistent with the association of TREM-2 and DAP12 phenotype in other systems (Bouchon et al., 2000; Kaifu et al., 2003; Turnbull et al., 2006).”
BackgroundRadsak, M. P., Salih, H. R., Rammensee, H., & Schild, H. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.8.4956 · Cited by 205
“TREM-1 induces rapid degranulation TREM-1 has been shown to induce the release of MPO and IL-8 (17).”
BackgroundResultInfluentialTessarz, A. S., & Cerwenka, A. (2008) · Immunology Letters · doi:10.1016/j.imlet.2007.11.021 · Cited by 202
Metalloproteinases Shed TREM-1 Ectodomain from Lipopolysaccharide-Stimulated Human Monocytes1
Gómez-Piña, V., Soares-Schanoski, A., Rodríguez-Rojas, A., del Fresno, C., García, F., Vallejo-Cremades, M. T., Fernández-Ruíz, I., Arnalich, F., Fuentes-Prior, P., & López-Collazo, E. (2007) · Journal of Immunology · doi:10.4049/jimmunol.179.6.4065 · Cited by 208
“However, only a single band of 900 bases corresponding to the previously described TREM-1 mRNA (1, 7, 23, 24) was detected in our cultures of human monocytes treated with LPS for indicated times.”
BackgroundInfluentialThe ITAM-bearing transmembrane adaptor DAP12 in lymphoid and myeloid cell function
Lanier, L. L., & Bakker, A. B. H. (2000) · Immunology Today · doi:10.1016/s0167-5699(00)01745-x · Cited by 203
Zarbock, A., Abram, C. L., Hundt, M., Altman, A., Lowell, C. A., & Ley, K. F. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20072660 · Cited by 201
Reprint of Neutrophil cell surface receptors and their intracellular signal transduction pathways
Futosi, K., Fodor, S., & Mócsai, A. (2013) · International Immunopharmacology · doi:10.1016/j.intimp.2013.11.010 · Cited by 207
From expression to signaling: Roles of TREM-1 and TREM-2 in innate immunity and bacterial infection
Sharif, O., & Knapp, S. (2008) · Immunobiology · doi:10.1016/j.imbio.2008.07.008 · Cited by 199
“TREM-1 consists of an extracellular domain, a transmembrane region which contains a conserved lysine residue (Ramanathan et al., 2005), and a short cytoplasmic domain, which lacks any signaling motif (Bouchon et al., 2000; Radaev et al., 2003; Kelker et al., ARTICLE IN PRESS”
BackgroundMethodInfluentialThe role of platelets in the recruitment of leukocytes during vascular disease
Rainger, G. E., Chimen, M., Harrison, M. J., Yates, C. M., Harrison, P., Watson, S. P., Lordkipanidzé, M., & Nash, G. B. (2015) · Platelets · doi:10.3109/09537104.2015.1064881 · Cited by 197
TREM2 in CNS homeostasis and neurodegenerative disease
Painter, M. M., Atagi, Y., Liu, C.-C., Rademakers, R., Xu, H., Fryer, J. D., & Bu, G. (2015) · Molecular Neurodegeneration · doi:10.1186/s13024-015-0040-9 · Cited by 169
“It contains an extracellular domain, a transmembrane domain, and a short cytoplasmic tail [26].”
BackgroundThe innate signaling of dangers and the dangers of innate signaling
Sansonetti, P. J. (2006) · Nature Immunology · doi:10.1038/ni1420 · Cited by 185
The mucosal immune system at the gastrointestinal barrier
Schenk, M., & Mueller, C. (2008) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2007.11.002 · Cited by 185
Elmezayen, R., Gazzar, M. E., Seeds, M. C., McCall, C. E., Dreskin, S. C., & Nicolls, M. R. (2007) · Immunology Letters · doi:10.1016/j.imlet.2007.04.011 · Cited by 178
“TREM-1 has been shown to synergize with TLRs to amplify the inflammatory response initiated by LPS [24] and induces TNF-α and IL-8 production [23].”
BackgroundDower, K., Ellis, D. K., Saraf, K. A., Jelinsky, S. A., & Lin, L. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.5.3520 · Cited by 181
“A contributing factor to positive cross-talk with prolonged treatment may be that PRR ligands can up-regulate TREM-1 expression (9, 11, 12, 23, 24).”
BackgroundThe Toll for Trafficking: Toll-Like Receptor 7 Delivery to the Endosome
Petes, C., Odoardi, N., & Gee, K. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01075 · Cited by 177
Allcock, R. J. N., Barrow, A. D., Forbes, S. A., Beck, S., & Trowsdale, J. (2003) · European Journal of Immunology · doi:10.1002/immu.200310033 · Cited by 173
Paradoxic inhibition of human natural interferon-producing cells by the activating receptor NKp44
Fuchs, A. G., Cella, M., Kondo, T., & Colonna, M. (2005) · Blood · doi:10.1182/blood-2004-12-4802 · Cited by 171
Identification and characterization of SKAT-2, a novel Th2-specific zinc finger gene
Blanchard, A. D., Page, K. R., Watkin, H., Hayward, P., Wong, T., Bartholomew, M. A., Quint, D. J., Daly, M. G., Garcia-Lopez, J., & CHAMPION, B. R. (2000) · European Journal of Immunology · doi:10.1002/1521-4141(200011)30:11 · Cited by 9
Evolution of effectors and receptors of innate immunity
Magor, B. G., & Magor, K. E. (2001) · Developmental & Comparative Immunology · doi:10.1016/s0145-305x(01)00029-5 · Cited by 166
Inhibitory ITAMs as novel regulators of immunity
Blank, U., Launay, P., Benhamou, M., & Monteiro, R. C. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00832.x · Cited by 175
“Indeed, incubation of these deficient cells with lipopolysaccharide (LPS) or CpG DNA induced higher production of tumor-necrosis factor-a (TNFa), interleukin-6 (IL-6), and IL-12 as compared with wildtype macrophages, suggesting that in wildtype macrophages, a DAP12 signal is required to limit TLR-induced cytokine prod…”
BackgroundInfluentialInflammatory mediators in major depression and bipolar disorder
Poletti, S., Mazza, M. G., & Benedetti, F. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-02921-z · Cited by 195
Ventilator-associated pneumonia: pathobiological heterogeneity and diagnostic challenges
Howroyd, F., Chacko, C. J., MacDuff, A., Gautam, N., Pouchet, B., Tunnicliffe, B., Weblin, J., Smith, F. G., Ahmed, Z., Duggal, N. A., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-50805-z · Cited by 198
KARAP/DAP12/TYROBP: three names and a multiplicity of biological functions
Tomasello, E., & Vivier, É. (2005) · European Journal of Immunology · doi:10.1002/eji.200425932 · Cited by 162
Genetics ignite focus on microglial inflammation in Alzheimer’s disease
Malik, M., Parikh, I., Vasquez, J. B., Smith, C., Tai, L., Bu, G., LaDu, M. J., Fardo, D. W., Rebeck, G. W., & Estus, S. (2015) · Molecular Neurodegeneration · doi:10.1186/s13024-015-0048-1 · Cited by 161
“The R47H variant blunts the TREM2-DAP12 response to anionic lipids [29]; therefore, the mutation may reflect a stage of TREM2 function intermediate between full function and the complete loss of function that is associated with the recessive Nasu-Hakola disease.”
InfluentialNovel biomarkers for sepsis: A narrative review
Larsen, F. F., & Petersen, J. A. (2017) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2017.09.030 · Cited by 162
Peripheral TREM1 responses to brain and intestinal immunogens amplify stroke severity
Liu, Q., Johnson, E. M., Lam, R. K., Wang, Q., Ye, H. B., Wilson, E. N., Minhas, P. S., Liu, L., Swarovski, M. S., Tran, S., et al. (2019) · Nature Immunology · doi:10.1038/s41590-019-0421-2 · Cited by 162
Tomasello, E., Desmoulins, P.-O., Chemin, K., Guia, S., Cremer, H., Ortaldo, J. R., Love, P. E., Kaiserlian, D., & Vivier, É. (2000) · Immunity · doi:10.1016/s1074-7613(00)00035-2 · Cited by 159
Haure-Mirande, J.-V., Audrain, M., Ehrlich, M. E., & Gandy, S. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00552-w · Cited by 159
“Of note, while a low level of TREM3 is detected in mouse microglia, TREM3 in humans is present as a pseudogene [56, 70, 106].”
BackgroundGuruswamy, R., & ElAli, A. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030496 · Cited by 166
“Abbreviations BBB, blood–brain barrier; rtPA, recombinant tissue-plasminogen activator; FDA, food and drug administration; ROS, reactive oxygen species; CD, clusters of differentiation; PRRs, pattern recognition receptors; TLRs, toll-like receptors; NLRs, nucleotide-binding oligomerization domain (nod)-like receptors;…”
BackgroundInfluentialErdman, L. K., Dhabangi, A., Musoke, C., Conroy, A. L., Hawkes, M., Higgins, S. J., Rajwans, N., Wolofsky, K. T., Streiner, D. L., Liles, W. C., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017440 · Cited by 159
“The TREM-1 receptor is expressed on the cell membrane of monocytes and neutrophils and mediates pro-inflammatory responses [37].”
Background
Metadata
- Authors
- Bouchon, A., Dietrich, J., & Colonna, M.
- Affiliations
- Basel Institute for Immunology , Basel ,
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2000-05
- Volume
- 164
- Issue
- 10
- Pages
- 4991-4995
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2149698238
- Semantic Scholar
- c6fffd66acdcb27c928605f7aca443056a3a6c3f
- Cited by
- 1,284
- References
- 13
- Citations by year
- 2026: 38 · 2025: 47 · 2024: 73 · 2023: 87 · 2022: 51 · 2021: 65 · 2020: 83 · 2019: 49 · 2018: 55 · 2017: 51 · 2016: 59 · 2015: 47 · 2014: 48 · 2013: 68 · 2012: 50
- FWCI
- 6.50
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Inflammation biomarkers and pathways
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Keywords
- TREM-1, neutrophils, monocytes, inflammation, IL-8 secretion, MCP-1, TNF-α, neutrophil degranulation, calcium mobilization, phospholipase C-gamma, myeloid cell activation
- MeSH terms
- Triggering Receptor Expressed on Myeloid Cells-1, Amino Acid Sequence, Fungi, Multigene Family, Gram-Negative Bacteria, Gram-Positive Bacteria, Humans, Immunoglobulins, Inflammation, Macrophage Activation, Membrane Glycoproteins, Membrane Proteins, Molecular Sequence Data, Molecular Weight, Monocytes, Neutrophils, Phosphorylation, Receptors, Immunologic, Tyrosine, Biomarkers, Up-Regulation, Cytokines, Neutrophil Activation, Chemokines, Calcium Signaling, Adaptor Proteins, Signal Transducing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review